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Cripavirus) elicits a non-infective immune
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Background: Dicistroviridae is a new family of small, non-enveloped, +ssRNA viruses pathogenic to both beneficial
arthropods and insect pests. Little is known about the dicistrovirus replication mechanism or gene function, and
any knowledge on these subjects comes mainly from comparisons with mammalian viruses from the Picornaviridae
family. Due to its peculiar genome organization and characteristics of the per os viral transmission route,
dicistroviruses make good candidates for use as biopesticides. Triatoma virus (TrV) is a pathogen of Triatoma
infestans (Hemiptera: Reduviidae), one of the main vectors of the human trypanosomiasis disease called Chagas
disease. TrV was postulated as a potential control agent against Chagas’ vectors. Although there is no evidence that
TrV nor other dicistroviruses replicate in species outside the Insecta class, the innocuousness of these viruses in
humans and animals needs to be ascertained.
Methods: In this study, RT-PCR and ELISA were used to detect the infectivity of this virus in Mus musculus BALB/c mice.
Results: In this study we have observed that there is no significant difference in the ratio IgG2a/IgG1 in sera from animals
inoculated with TrV when compared with non-inoculated animals or mice inoculated only with non-infective TrV protein
capsids.
Conclusions: We conclude that, under our experimental conditions, TrV is unable to replicate in mice. This study
constitutes the first test to evaluate the infectivity of a dicistrovirus in a vertebrate animal model.
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Dicistroviridae is a recently established family of small,
non-enveloped viruses, containing a +ssRNA genome, and
is classified under the order Picornavirales. This family con-
tains 14 members classified within two genera, Cripavirus
(type species Cricket paralysis virus, CrPV), and Aparavirus
(type species Acute bee paralysis virus, ACP) [1,2]. A third
genus has been recently proposed, Triatovirus (type species
Triatoma virus, TrV) [3]. All dicistroviruses are pathogenic
to arthropods, although primarily to insects, representing
significant threats to the health of beneficial arthropods
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reproduction in any medium, provided the orKashmir bee virus, which infects honeybees [4-6], and
Taura syndrome virus, which is pathogenic to shrimps [7].
Two dicistrovirus members infect the model organism
Drosophila melanogaster, Drosophila C virus (DCV)
and CrPV [8,9], and eight of them are pathogenic to in-
sect pests, as it is the case with CrPV, which infects
field crickets and the Olive Fruit Fly as well [7]. The
aforementioned CrPV is quite ubiquitous and replicates
in many other insect species spanning five orders [10].
Although dicistroviruses are believed to be arthropod-
specific, antibodies against CrPV have been detected in
sera from a pig, horse, and cattle [11]. Similarly, high
levels of anti-TrV antibodies were detected in chickens
used to feed a colony of TrV-infected insects, although
the authors of this work concluded that the chickens were
apparently refractory to the infection with TrV [12].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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known about dicistrovirus infection, replication mechan-
ism or gene function. Most information about cellular
infection and the replication cycle of dicistroviruses
comes from studies on DCV, and by comparison with
mammalian picornaviruses [1]. Many members of the
Dicistroviridae family are considered novel candidates to
be used as biopesticides [1,13-17].
TrV and Solenopsis invicta virus-1 are the two lone
members of the Dicistroviridae family that infect insects
of medical importance [1]. In fact, TrV is a natural
enemy of Triatoma infestans (Hemiptera: Reduviidae),
one of the main vectors of the trypanosomiasis disease
called Chagas disease, a severe human illness most
prevalent in almost all Latin American countries [18,19].
To date, TrV is the only entomopathogenic virus found
in triatomines [20]. The viral particles are spherical, with
a diameter of 30 nm [21], and consist of a non-
enveloped capsid that encloses a 9010 nt long viral gen-
ome [22]. The capsid contains four structural proteins
VP1 (29.7 kDa), VP2 (28.4 kDa), VP3 (31.8 kDa) and a
minor one VP0 (37.3 kDa). In addition to these four
structural proteins, this virus has a low molecular weight
protein of 5.5 kDa that appears to be detached from the
capsid, lying at the particle interior and presumably in
contact with the genome [3,20,23]. TrV can also infect
natural populations of T. sordida and several experimen-
tal populations of triatomines as well [24]. Viral replica-
tion takes place in the midgut epithelium cells of
triatomines, causing many deleterious sublethal effects
in T. infestans and T. patagonica colonies, such as reduc-
tion of the longevity, increase of the developmental time,
a decrease in both fecundity and fertility of eggs, and even
a cumulative mortality higher than 97% [16,25-28].
As pointed out previously, the infectivity of TrV in
vertebrates remains unclear. Therefore, in this work we
studied the infectivity of TrV in mice (Mus musculus -
BALB/c mice). Our results indicate that inoculations of
both infective and non-infective TrV particles elicit the
same immune response, and that this insect virus is
unable to replicate in this animal model. Based on the
bicistronic character of dicistrovirus genomes, it was
speculated that these pathogens may not infect verte-
brates, and this report constitutes important experimen-
tal evidence to support that hypothesis.
Methods
Triatoma virus purification
Virus purification was performed according to [3]. Dry
feces obtained from infected insects were collected on
Whatman filter papers and excised from them using a
standard surgery scalpel until two g of material was col-
lected. A buffer composed of 10 mM NaCl, 1 mM
MgCl2 and 200 mM citric acid at pH 6 (Lysis buffer)was added at a ratio of 100 mL per gram of dry material.
PMSF (N 98.5%, purchased from Sigma) thawed at
−20°C in isopropanol (Merck, GR for analysis) was
added up to a final concentration of 1 mM. The mixture
was homogenized for 5 min using a vortex mixer and
then sonicated using a Sanyo MSE Soniprep 150 operat-
ing at 10 s ON/10 s OFF for 20 pulses. After centrifuga-
tion, the resulting pellet was resuspended in NMT
buffer and then loaded on top of a 35 mL continuous
5%–30% sucrose gradient. The gradients were cooled in
ice to avoid particle diffusion within them. The individ-
ual optical density of each aliquot was then measured at
both 260 nm and 280 nm. After plotting the absorbance
profile, selected aliquots were loaded onto 12.5% poly-
acrylamide SDS-PAGE gels to check the purity of the
samples. Following gradient fractionation, equivalent
samples were pooled together and dialyzed overnight
against 2 L of NMT buffer.
Infection with Triatoma virus (TrV)
Eight groups of female Mus musculus BALB/c mice (3
mice per group) between 5 and 8 weeks of age obtained
from Instituto de Higiene e Medicina Tropical, Lisbon,
Portugal, were used in the experimental infection with
TrV. Groups 1-5 were inoculated by intraperitoneal in-
jection. Group 1 is the control group, which was inocu-
lated only with PBS. Group 2 was inoculated with 3.0 μg
of empty TrV particles (capsids without genome, there-
fore non-infective) [3]. Group 3 was inoculated with 3.0
μg of TrV, group 4 and group 5 with 0.3 μg and 0.03 μg
of TrV respectively. Group 6 served as a negative control
of per os inoculation, therefore it was inoculated only
with 100 μl of PBS delivered per os intraesophageally by
using a 1 ml tuberculin syringe and Gavage needle.
Group 7 was inoculated with 3.0 μg of empty TrV parti-
cles in 100 μl of PBS, delivered per os intraesophageally
by using a 1 ml tuberculin syringe and Gavage needle.
Group 8 was inoculated with 3.0 μg of TrV in 100 μl of
PBS, delivered per os intraesophageally by using a 1 ml
tuberculin syringe and Gavage needle. After inoculation
blood and feces samples were collected at different times
(3, 7, 30 and 45 days). Forty-five days after inoculation,
the animals were sacrificed.
All experiments on animals were conducted with prior
approval from the Animal Welfare of General Manage-
ment of Veterinarians (DGV - Portugal). All manipula-
tions of mice satisfied the requirements of the Regulations
of Experimental Animal from the Ethics Committee of
IHMT/UNL-Portugal.
Searching for TrV in blood and feces samples
Blood samples from each mouse were collected into in-
dividual micro tubes containing 5 μl of Heparin-Sodium
(B. Braun, USA). The RNA was extracted according to
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Kits, (Bioline, UK). RNA concentration was determined
by measuring absorbance at 260 nm (Abs260) in a spec-
trophotometer (NanoDrop 1000, Thermo Scientific).
Feces samples were collected into micro tubes. For each
group of mice we pooled the samples from all mice of this
group. 1,2 mg of fecal samples resuspended in 200 μl PBS
were homogenized and centrifuged (5,000 rpm) for 10-15
minutes. 50 μl of supernatant was then homogenized in
TRIZOL reagent (Genbiotech, Argentina), and viral RNA-
TrV (vRNA) was purified according to the manufacturer’s
instructions. As a positive control of RNA extraction, we
carried out the same procedure simultaneously with feces
from triatomines infected with TrV.
Purified vRNA (0.724 μg) was used as a template for
the positive control in the RT-PCR reaction. For the
other RT-PCR, we used 5 μl of the samples resulting
from the purification of the vRNA from blood and feces
samples from the mice used in the infectivity experi-
ment. The cDNA synthesis was performed according to
the cDNA Synthesis Kit protocol (Bioline, UK). 5 μl of
the extraction product was used according to the
OneStep RT-PCR protocol (QIAGEN; USA). TrV posi-
tive PCR reactions have a 832 bp product according to
the protocol established in our previous work [26]. As a
positive control of RT-PCR and RNA extraction from
blood samples, we performed a PCR with two primer
pairs from β-actin gene: β-actin sense: 5´ TGGAATC
CTGTGGCATCCATGAAAC 3´ and β-actin anti-sense:
3´ TAAAACGCAGCTCAGTAACAGTCCG 5´, with an
expected product of 348 bp [29]. PCR products were vi-
sualized on 1.5% agarose gels for TrV and 2% agarose
gel for β-actin, stained with ethidium bromide, and their
sizes were determined by comparison against DNA
markers, HyperLadder I (Bioline, UK) and HyperLadder
IV (Bioline, UK) respectively.
Production of mouse polyclonal antibodies to anti-TrV
The serum used as a positive control in ELISA reactions
were produced in female Mus musculus BALB/c mice
between 5 and 8 weeks of age. The mice were inoculated
(subcutaneous injection) with 100 μg of empty TrV par-
ticles mixed with 100 μl of Freund’s complete adjuvant
(Sigma-Aldrich, USA). Fifty days after the first inocula-
tion, the animals were inoculated with 100 μg of empty
TrV particles mixed with 100 μl of Freund’s incomplete
adjuvant (Sigma-Aldrich, USA). Ten days after the sec-
ond inoculation, the animals were sacrificed and hyper-
immune sera was obtained.
Detection of anti-TrV IgGs antibodies by ELISA
Naturally empty TrV particles were selected as antigens
for their protein-only composition. These particles con-
tain almost the same proteins as full particles, but atleast 30% of its composition was integrated by 7 additional
polypeptides that were determined to be misprocessed
products from the cleavage of the structural protein pre-
cursor P1 [3]. Nevertheless, since both full and empty par-
ticle proteins share the same origin (P1), their antigenic
properties remain essentially the same.
Three different concentrations of total proteins (50, 100
and 150 ng/well) from the empty TrV particles were used
to optimize the amount of antigen used in this reaction.
We chose 100 ng/well because with this value the amount
of antigen is no longer the limiting reagent of the reaction.
Total protein extract from empty TrV particles (in car-
bonate buffer pH 8.5) was adsorbed overnight at 4°C onto
96-well micro-plates (Nunc, Denmark) for use in indirect
enzyme-linked immunosorbent assays (ELISA), using sera
from inoculated mice. Subsequently, horseradish peroxid-
ase, (HRP)-conjugated rat anti-mouse IgG (1:4000, Sigma-
Aldrich, USA), rat anti-mouse IgG1 (500 ng/ml, AbD
serotec, UK) or rat anti-mouse IgG2a (250 ng/ml, AbD
serotec, UK) were used.
Results
Absence of clinical infection signals
Mice inoculated with TrV by intraperitoneal and per os
route did not show any behavioral alteration or clinical
signals of viral infection (e.g. leg paralysis, change in
food intake rate, weight loss, decrease in motility and
death), when compared with mice inoculated with empty
TrV particles or saline solution (control groups), this is
contrary to what happens in triatomines, where the in-
sects inoculated with the virus show leg paralysis, de-
layed development and death [16,22].
Absence of TrV in blood and feces samples
We analyzed all blood and feces samples from each
group of animals at 0, 3 and 45 days after inoculation.
No RT-PCR products corresponding to TrV were
detected from blood or feces samples of any of the
groups of mice inoculated with TrV or mice inoculated
with empty TrV particles (Figure 1). All blood samples
showed PCR products corresponding to β-actin gene,
with expected size (348 bp) (Figure 1-D).
Detection anti-TrV IgGs antibodies by ELISA
We performed ELISA to detect antibodies against TrV
in sera extracted from inoculated mice. Total protein ex-
tract from empty TrV particles was used to detect the
presence of anti-TrV antibodies in sera from non-
inoculated and inoculated BALB/c mice with TrV. We
produced polyclonal antibodies to anti-TrV in mice in
order to establish basal and positive signals in the
ELISA. The cut-off value was defined using sera from
non-inoculated mice, mean OD (optical density) + 3SD
(standard deviation) at 490 nm. We chose this weighting
Figure 1 A), B) and C) RT-PCR products with TrV primers on 1.5% agarose gel stained with ethidium bromide, at zero, three and forty-
five days after inoculation respectively. HL I: 200 bp to 10000 bp; Lane 1: negative control of RNA extraction; 2: IP with PBS; 3: IP with 3 μg
empty TrV particles; 4: IP with 3 μg TrV; 5: IP with 0.3 μg TrV; 6: IP with 0,03 μg TrV; 7: Per os with PBS; 8: Per os with 3 μg empty TrV particles;
9: Per os with 3 μg TrV; 10: Negative control of RT-PCR, 11: 12.5 ng of pDNA (TrV). D) RT-PCR products with β-actin primers on 2% agarose gel
stained with ethidium bromide forty-five days after inoculation. HL IV: 100 bp to 1000 bp; Lane 1: negative control of RNA extraction; 2: IP with
PBS; 3: IP with 3 μg empty TrV particles; 4: IP with 3 μg TrV; 5: IP with 0,3 μg TrV; 6: IP with 0.03 μg TrV; 7: Per os with PBS; 8: Per os with 3 μg
empty TrV particles; 9: Per os with 3 μg TrV.
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OD values less than the cut-off value.
Forty-five days after intraperitoneal inoculations, all
inoculated mice showed high levels of IgG anti-TrV anti-
bodies when compared with sera from non-inoculated
mice (Figure 2) or mice inoculated by per os route. Sera
reactivity was directly proportional to the amount of
antigen used in inoculation. However, there was no sig-
nificant difference (F = 0.0064; p-value > 0.05) between
the reactivity of sera from mice inoculated with empty
TrV particles to that of mice inoculated with the same
amount of RNA-full TrV capsid (Additional file 1). All
mice inoculated by the per os route presented levels of
anti-TrV antibodies similar to mice inoculated only with
PBS (Figure 2), indicating that per os inoculation with TrV
produces little or no IgG antibody response in mice.
To define which subclasses of IgG anti-TrV were
detected in sera from inoculated mice and in order to
determine if TrV can replicate in mice, we measured the
titers of IgG1 and IgG2a antibodies specific to TrV
(Figure 2-B and C). The results show that there is no
significant difference in the IgG2a/IgG1 ratio between
mice inoculated with TrV, mice inoculated with empty
TrV particles or non-inoculated mice (Figure 2-D).Discussion
RT-PCR has been used to detect a variety of RNA vi-
ruses in different kinds of samples [9,30]. In this study, a
RT-PCR assay has been developed to detect TrV from
blood and feces samples from mice inoculated with TrV.
Two specific pairs of primers for TrV were used and the
832 bp products expected for the TrV-specific assay
were produced only when TrV vRNA was present, indi-
cating that this assay is highly specific for TrV.
In this PCR assay, PCR products were detected from
samples with low concentrations of plasmid DNA (6.2
pg) encoding specific TrV sequences or TrV vRNA (2.5
ng) (data not shown). Therefore, if TrV were able to rep-
licate in mice, their presence would be detected by RT-
PCR assay from blood and feces samples of inoculated
mice. However, we were not able to detect any PCR
products from blood or fecal samples of mice inoculated
with TrV. The absence of PCR products from these sam-
ples may indicate that TrV is unable to replicate in mice,
this contrasts to what happens in triatomines, where this
virus causes a high mortality rate, reduces fecundity and
delays the development of infected insects [16,25].
It has been postulated that the immune response trig-
gered by viruses mainly activates the Th1 subset of T
Figure 2 A) Levels of total IgG anti-TrV antibodies, B) Levels of total IgG1 anti-TrV antibodies, C) Levels of total IgG2a anti-TrV
antibodies elicited in mice BALB/c inoculated with empty TrV particles (eTrV) and RNA-full TrV capsids (TrV); D) ratio IgG2a/IgG1
antibodies. Serum samples were taken on days 45 after injection. Each column represents the mean with standard deviation (SD) from the
ratio of optical density (OD490 nm) and cut-off values (three mice per group). Cut-off value was defined as: mean + 3SD. Abbreviations: IP:
intraperitoneal route; PAb: Polyclonal antibodies.
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which is the reason many systemic viral infections in
mice result in preferential increases in virus-specific
IgG2a antibodies in serum [31,32]. This preferential class
switch is dependent on viral replication and is attributed
in part to virus-induced production of IFN-γ [31]. In this
study we observed that there is no significant difference
in the ratio IgG2a/IgG1 in sera from animals inoculated
with TrV when compared with non-inoculated animals
or mice inoculated only with empty TrV particles. The
results reported in this work support the idea that TrV
is unable to replicate in vertebrates.
Conclusions
The results of the ELISA for anti-TrV together with the
results of a TrV vRNA search by RT-PCR in blood and
feces samples from mice inoculated with TrV indicatethat this virus is not infective in mice, at least under the
conditions explored in this study (infected by per os and
intraperitoneal inoculations). The results reported in this
work support the idea that TrV is a virus that only in-
fects invertebrates.
To date, this study constitutes an important approach to
evaluate the response of one vertebrate animal model to
the experimental infection with a dicistrovirus. Future
studies may lead to a better understanding of the TrV host
range, and hopefully may also characterize the effect ob-
served in humans and other vertebrates that are most
likely to be exposed to dicistroviruses [10,22]. Certainly, to
improve the current knowledge on TrV, and in general, to
gain information on the life cycle of any member of the
Dicistroviridae family, will greatly help in establishing a
proof of principle for employing dicistroviruses as bio-
logical agents to control insect pests.
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Additional file 1: Statistical analysis (ANOVA, with Microsoft ExcelW)
between the two groups of mice inoculated with the same
concentration of RNA-full TrV capsids and empty TrV particles
respectively (3 μg). Considering that the data is normally distributed,
this test helped to identify differences between mice inoculated with TrV
and mice inoculated with the same amount of empty TrV particles. The
null hypothesis (H0) assumes that the means are statistically the same
(H0: μ1 = μ2), and the alternate hypothesis (HA) assumes that the means
are statistically different (HA: μ1 ≠ μ2), at 95% confidence. Since the F
statistic is smaller than the critical value, we fail to reject the null
hypothesis. Sum of squares (SS); Degrees of freedom (df); Mean square (MS).
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